Apple representatives met with people from the U.S. Food and Drug Administration (FDA) on December 13 to discuss medical applications for wearable devices . The meeting is recorded in the FDA's public records, which list the date, the topic of the discussion, and the names of the representatives from both sides who took part.
The news came to light last Friday, confirming reports that have been appearing since the end of last year, which claim that the American company is developing hardware and software to record various biological parameters.
On the occasion of the meeting, the New York Times returned to the topic, reporting that the hardware will be integrated into the long-awaited iWatch, a “smart” watch with biosensors that will wirelessly transmit their measurements to the iPhone . In fact, in an article in its Sunday edition, the newspaper reports that Apple is examining various technologies to replenish the battery’s electrical energy – such as magnetic induction or the integration of small solar cells.
Technology site 9to5Mac provides even more details, reporting that the storage and analysis of biological measures will be one of the main new features of the next version of Apple's operating system for iPhone and iPad. Thus, in the new version, the operating system will include "Healthbook", an application that will collect data such as heart rate or blood pressure.
A leaked meeting between the FDA and Google executives about a medical innovation the internet giant was developing was leaked about a month ago. It was revealed a few days later that the innovation involves the first “smart” contact lenses that would be able to measure the sugar level in the tears of diabetics.
